Key result
Presence of Coxsackievirus B1 antibodies was associated with an increased risk of newly diagnosed type 1 diabetes in children.
Why the study?
Is the presence of Coxsackievirus B1 antibodies associated with an increased risk of newly diagnosed type 1 diabetes in children?
Case-Control (n=498)
Yes
Is the presence of Coxsackievirus B1 antibodies associated with an increased risk of newly diagnosed type 1 diabetes in children?
The study suggests an association between Coxsackievirus B1 and type 1 diabetes, highlighting its possible role as a diabetogenic virus.
Answers are grounded in this paper and cite their sources.
Suggests enteroviral triggers in pediatric type 1 diabetes; hypothesis-generating and requires prospective confirmation before clinical application.
Enteroviruses (EVs) have been connected to type 1 diabetes in various studies. The current study evaluates the association between specific EV subtypes and type 1 diabetes by measuring type-specific antibodies against the group B coxsackieviruses (CVBs), which have been linked to diabetes in previous surveys. Altogether, 249 children with newly diagnosed type 1 diabetes and 249 control children matched according to sampling time, sex, age, and country were recruited in Finland, Sweden, England, France, and Greece between 2001 and 2005 (mean age 9 years; 55% male). Antibodies against CVB1 were more frequent among diabetic children than among control children (odds ratio 1.7 [95% CI 1.0-2.9]), whereas other CVB types did not differ between the groups. CVB1-associated risk was not related to HLA genotype, age, or sex. Finnish children had a lower frequency of CVB antibodies than children in other countries. The results support previous studies that suggested an association between CVBs and type 1 diabetes, highlighting the possible role of CVB1 as a diabetogenic virus type.
No takes yet. Share an insight, caveat, or question.
Oikarinen et al. (2013) conducted a case-control in Type 1 diabetes (n=498). Coxsackievirus B1 (CVB1) antibodies vs. Matched control children was evaluated on Type 1 diabetes (OR 1.7, 95% CI 1.0-2.9). Presence of Coxsackievirus B1 antibodies was associated with an increased risk of newly diagnosed type 1 diabetes in children.
Synapse has enriched 10 related papers. Consider them for comparative context: